Related Experiment Video
Updated: Aug 26, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Ventricular arrhythmias in Kearns-Sayre syndrome: A cohort study using the National Inpatient Sample database
Kyle Wiseman1, Dhairya Gor1, Ndausung Udongwo1
1Department of Medicine, Hackensack Meridian Jersey Shore University Medical Center, Neptune, New Jersey, USA.
Insights
Patients with Kearns-Sayre syndrome (KSS) have a lower risk of ventricular arrhythmias (VA) than those with myotonic dystrophy (MD). Permanent pacemaker (PPM) use is underutilized in KSS patients with conduction abnormalities, despite its benefits.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Kearns-Sayre syndrome (KSS) is associated with cardiac conduction system degeneration, leading to complete heart block (CHB), ventricular arrhythmias (VA), and sudden cardiac death (SCD).
- Permanent pacemaker (PPM) implantation is a potential preventive measure for SCD in KSS, but the efficacy of defibrillators and other SCD mechanisms require further investigation.
Purpose of the Study:
- To investigate the risk of VA or dysrhythmic cardiac arrest (dCA) in patients with KSS.
- To compare cardiac outcomes and device implantation strategies between KSS and myotonic dystrophy (MD) patients.
Main Methods:
- Utilized the National Inpatient Sample (NIS) database from 2016-2019.
- Compared outcomes of 640 KSS admissions to those with MD, focusing on VA/dCA incidence and device implantation.
Main Results:
- KSS patients had a significantly lower incidence of VA or dCA compared to MD patients (2.3% vs. 4.5%, p=0.009).
- Conduction abnormalities were linked to higher VA/dCA rates in both groups.
- PPM (±defibrillator) was implanted in ~70% of KSS patients with conduction abnormalities at discharge, versus 35% in MD patients.
Conclusions:
- PPM is underutilized in KSS and MD patients with conduction abnormalities, despite its effectiveness in preventing VA.
- PPM alone may not fully prevent VA in MD; defibrillator capacity might be necessary.
Background:
Degeneration of the cardiac conduction system resulting in complete heart block (CHB), ventricular arrhythmias (VA), and sudden cardiac death (SCD) is recognized in patients with Kearns-Sayre syndrome (KSS) and is potentially preventable with permanent pacemaker (PPM) implantation. However, other mechanisms for SCD have been proposed, and the efficacy of implanting a defibrillator instead of PPM remains to be investigated.
Methods:
We utilized the National Inpatient Sample (NIS) database 2016-2019 to investigate the risk of VA or dysrhythmic cardiac arrest (dCA) in KSS patients. We compared the outcomes of KSS to myotonic dystrophy (MD), a more common genetic disorder with similar clinical cardiac features and course.
Results:
We identified 640 admissions for KSS. VA or dCA were lower in admissions for KSS than MD patients (2.3% vs. 4.5%, p = .009). Device implantation differed between study groups. Approximately, 70% of cases with KSS and conduction abnormalities had pacemaker (± defibrillator) on hospital discharge, compared to 35% in MD. Conduction abnormalities were associated with higher rates of VA or dCA in both study groups. None of the admissions for KSS patients who developed VA or dCA had a pacemaker, and all of them had conduction abnormalities. One-third of admissions for MD patients who developed VA or dCA had a device already implanted prior to the event.
Conclusion:
Despite its effectiveness in preventing VA, PPM remains underutilized in patients with KSS or MD who have conduction abnormalities. PPM alone do not fully prevent VA in MD patients; therefore, addition of defibrillator capacity might be necessary.
Related Concept Videos
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mechanism of Cardiac Arrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
Electrophysiology of Normal Cardiac Rhythm
Dysrhythmias I: Introduction

